Form 8-K - Current report:
SEC Accession No. 0001104659-16-101458
Filing Date
2016-03-01
Accepted
2016-03-01 16:42:12
Documents
1
Period of Report
2016-02-25
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K a16-5538_18k.htm 8-K 18817
  Complete submission text file 0001104659-16-101458.txt   19727
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 161473929
SIC: 2834 Pharmaceutical Preparations